Transcription factor EB is involved in autophagy-mediated chemoresistance to doxorubicin in human cancer cells

Nature·Jun 12

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Research suggests that transcription factor EB plays a role in autophagy-mediated chemoresistance to doxorubicin in human cancer cells. This involvement may contribute to the development of resistance to the chemotherapy drug. The relationship between transcription factor EB and chemoresistance is being studied in the context of human cancer cells.

Full coverage

Transcriptional and epigenetic regulation of autophagy: mechanisms, disease relevance and therapeutic opportunities

Nature·Jun 4

Autophagy in doxorubicin resistance: basic concepts, therapeutic perspectives and clinical translation

Frontiers·Sep 30

Autophagy and cancer: Modulation of cell death pathways and cancer cell adaptations | Journal of Cell Biology

Rockefeller University Press·Nov 21

Targeting autophagy using natural compounds for cancer prevention and therapy

Wiley & Sons·Feb 12

The MicroRNA-Based Strategies to Combat Cancer Chemoresistance via Regulating Autophagy

Frontiers·Jun 30

A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer

Nature·Apr 3

HSF1 at the crossroads of chemoresistance: from current insights to future horizons in cell death mechanisms

Frontiers·Jan 8

Gemcitabine promotes autophagy and lysosomal function through ERK- and TFEB-dependent mechanisms

Nature·Feb 6

View original report at Nature ↗

Fetching the latest headlines…